RM 191A / RR MedSci - LARVOL DELTA

Topical RM191A gel for chronic peripheral neuropathic pain: randomized, double-blind, placebo-controlled, crossover pilot study. (PubMed, Front Pain Res (Lausanne)) - "The NNT of 8 compares favorably with topical lidocaine (14.5) and is similar to duloxetine (7.4) and gabapentinoids (8.9). ANZCTRN 12617000206325. https://www.anzctr.org.au/."

Clinical • Journal • Neuralgia • Pain • Peripheral Neuropathic Pain

Skin protective and regenerative effects of RM191A, a novel superoxide dismutase mimetic. (PubMed, Redox Biol) - "RM191A topical gel is found to be non-toxic, non-teratogenic and readily distributed in the body of mice. Moreover, it significantly accelerates excisional wound healing, reduces 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation and attenuates age-associated oxidative stress in skin, demonstrating both skin regenerative and geroprotective properties of RM191A."

Journal • Immune Modulation • Immunology • Inflammation